Rezilir in the Media
From national health headlines to leading brain-health podcasts, see where Dr. Craig Tanio and the Rezilir Health team are shaping the conversation on cognitive health, longevity, and complex chronic illness.
As featured in
HuffPost
USA TODAY
The Palm Beach Post
New Scientist
The Scotsman
Dhru Purohit Podcast
In the news
Recent coverage, from local features to national headlines.
Featuring Dr. Craig Tanio, co-founder of Rezilir Health and co-investigator on the Evanthea Dementia Trial. Headlines below are the outlets’ own titles.
HuffPost
Featured expert
Doing These 5 Activities With Loved Ones May Help Ward Off Dementia
Dr. Tanio on why “relationships are compounding investments” for lifelong brain health.
April 2026
The Palm Beach Post
Expert quote
Hormone Replacement Therapy, Once Warned Against, Is Making a Comeback
Dr. Tanio on bioidentical hormones as a key intervention for cognition and brain fog.
May 2026
USA TODAY
Evanthea trial coverage
New Clinical Trial Documents Reversal of Cognitive Decline
National “Fighting Alzheimer’s” feature on the trial Rezilir Health serves as a clinical site for.
June 2026
The Palm Beach Post
Expert quote
Can Money Buy You Alzheimer's Protection?
Dr. Tanio offers the measured, science-anchored view on precision-medicine approaches to Alzheimer’s.
June 2026
The Scotsman
Expert quote
Trial Reports Preliminary Findings on Cognitive Function in Early Dementia Patients
“These preliminary results open the door to a future where cognitive decline is no longer accepted as inevitable,” said Dr. Craig Tanio.
June 2026
New Scientist
Evanthea trial coverage
Symptoms of Early Dementia Reversed by Bespoke Treatment Plans
Coverage of the randomized controlled trial of personalized, multi-factor cognitive care.
April 2026
Podcasts and interviews
Dr. Tanio in conversation.
Long-form conversations with leading voices in functional and precision medicine.
Fast Metabolism Matters · Haylie Pomroy
Why Chronic Illness Needs a Different Kind of Healthcare
Dr. Tanio on why chronic illness demands multimodal care, and how patients can find providers who treat root causes instead of managing symptoms.
June 30, 2026
Alzheimer’s Breakthrough · Dr. Josh Helman, MD
Can Alzheimer's Be Reversed? New Trial Results Revealed
A systems view of cognitive decline, spanning metabolism, inflammation, hormones, and toxins, plus the Evanthea trial results.
June 25, 2026
Rational Wellness Podcast · Dr. Ben Weitz
The Real Causes of Alzheimer's Disease
Dr. Tanio unpacks the root causes of Alzheimer’s and the precision-medicine approach to cognitive decline.
April 8, 2026
Thinkwell Agewell · Dr. Heather Sandison, ND
Inside Precision Medicine: What the EVANTHEA Trial Reveals About Brain Health
How treating multiple root causes at once may change the trajectory of cognitive decline.
April 7, 2026
Apollo Health Webinar · With Dr. Dale Bredesen
2025 Randomized Controlled Trial Results
Drs. Bredesen and Tanio present findings from the precision-medicine trial for MCI and early Alzheimer’s.
January 26, 2026
Hope & Help For Fatigue & Chronic Illness · Haylie Pomroy, NSU Institute for Neuro-Immune Medicine
Integrative Approaches to Brain Health
The immune system’s role in cognition, Long COVID’s impact on the brain, and multimodal care.
July 2, 2024
Dhru Purohit Podcast
How Mold and Environmental Toxins Damage Our Brain and Body
Dr. Tanio on mycotoxins, neuroinflammation, and finding the root causes behind brain fog.
May 24, 2021
For journalists and producers
Media and Press Inquiries
For interview requests, speaking engagements, or press materials featuring Dr. Craig Tanio and the Rezilir Health team, we would love to hear from you.
Disclaimer: This website is provided for informational purposes only and does not constitute endorsement of treatments, individuals, or programs which appear herein. Any external links on the website are provided for the visitor’s convenience; once you click on any of these links you are leaving the Rezilir Health® website. Rezilir Health® has no control over and is not responsible for the nature, content, and availability of those sites.